Abstract
Differences in formulation are of greater clinical importance in the case of sparingly soluble drugs, those with small therapeutic doses, in replacement therapy and in the control of serious clinical conditions with compounds having a low therapeutic index: this subject should receive specific attention in medical teaching and in clinical trials.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Freestone D. S. Formulation and therapeutic efficacy of drugs used in clinical trials. Lancet. 1969 Jul 12;2(7611):98–99. doi: 10.1016/s0140-6736(69)92406-4. [DOI] [PubMed] [Google Scholar]
- Johnson B. F., Greer H., McCrerie J., Bye C., Fowle A. Rate of dissolution of digoxin tablets as a predictor of absorption. Lancet. 1973 Jun 30;1(7818):1473–1475. doi: 10.1016/s0140-6736(73)91811-4. [DOI] [PubMed] [Google Scholar]
- Tyrer J. H., Eadie M. J., Sutherland J. M., Hooper W. D. Outbreak of anticonvulsant intoxication in an Australian city. Br Med J. 1970 Oct 31;4(5730):271–273. doi: 10.1136/bmj.4.5730.271. [DOI] [PMC free article] [PubMed] [Google Scholar]